Senior insider sale
Chief Business Officer at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$3.43M
82.20K shares
What this filing means
KREMPA DAVID plans to sell 82.20K shares of ETON PHARMACEUTICALS, INC. valued at approximately $3.43M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/24/2026ACC: 0001974078-26-000328
Officer· Chief Business Officer
Since Mar 2023
82.20K
Shares to sell
$3.43M
Approx. market value
25K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/24/2026
25KTotal acquired25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/24/2026 | Stock Option Exercise Cash | 25K | — |
| Total | 25K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
19.68K
Market value
$618.6K
5/27/2026
—Completed
Units to sell
37.52K
Market value
$1.18M
5/26/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
25K
Market value
$1.63M
8/24/2026
Total
Units
82.20K
Value
$3.43M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/27/2026 | 19.68K | $618.6K | — | Completed |
5/26/2026 | 37.52K | $1.18M | — | Completed |
| Planned — Approximate Date | ||||
8/24/2026 | 25K | $1.63M | Nasdaq | Planned |
| Total | 82.20K | $3.43M | ||